knowledge -WSS

knowledge

author：Wikipedia 2025-10-01 16:38:25 - browse：8875

Sutter Health Palo Alto Medical Foundation facilities. health tech coverage from STAT — Adobe

When Sutter Health was on trial for anticompetitive conduct in 2022, the San Francisco jury missed out on some crucial details. They didn’t hear, for example, how its former finance chief said the system would make an extra $200 million per year by making insurers contract with all of its hospitals instead of just a few. Or how its former CEO said, “Related to the health plans, we force them to pay us more.”

That evidence was indeed relevant, and the judge erred by not allowing it to be presented during the month-long trial that concluded in March 2022, a U.S. appeals court wrote in its ruling on Tuesday. The Ninth Circuit panel overturned Sutter’s win in the class-action case alleging that Sutter used its market power to drive up health care costs across the region by more than $400 million. Tuesday’s decision means the case will likely get a second trial.

“Effectively, the appellate court said the jury was tainted,” said Matthew Cantor, lead counsel for the plaintiffs. “So the jury’s verdict is discarded.”

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the financial innards of our health care system — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： Spinal cord stimulation reduces pain in amputees, study finds

WSS

Leukemia patients are helped by Syndax's new type of therapy

Sanofi says it has 12 blockbusters on the way. Will investors believe it?

Despite FDA approval for Lyfgenia, Bluebird faces stiff competition

Dementia risk linked to living in disadvantaged areas: Study

CMS should re

Caribou posts encouraging results on off

focus

knowledge

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the financial innards of our health care system — by subscribing to STAT+.

leisure time

Psychedelics group wrestles with new pharma identity

Sanofi says it has 12 blockbusters on the way. Will investors believe it?

Hepatitis C has a cure — but many Americans still lack access to it

STAT Event – Decoding Clinical Trials: Venture Capitalists Talk Early Biotech R&D

Anesthesiologist group: stop taking Ozempic before surgery

Spinal cord stimulation reduces pain in amputees, study finds

Walensky prepares to leave CDC — and Congress — behind

In rare move, senator releases unverified FBI source report alleging Biden bribe

Malaria cases in Florida and Texas: Here’s what you need to know

There’s a way to spot data fakery. All journals should be using it

hotspot

Jan. 6 charges against Trump would add to his mounting legal peril as he campaigns for 2024

Roche to buy Carmot Therapeutics, developer of obesity drugs

STAT letters to the editor on burnt

What causes an itch? Researchers may have solved the mystery

A new ‘biological computer' targets cancer while sparing healthy cells

This biotech could one day make human eggs from scratch. But first, they’re trying to rethink IVF

explore

hotspot

entertainment

leisure time